2012 annual financial data
Addex Therapeutics 2012 Net margin
Addex Therapeutics 2012 net margin with verified reported values.
Direct answer
Net margin was -21,976.79%.
Operating income was -27,010,414 CHF and net income was -26,611,480 CHF.
Operating cash flow was -29,452,938 CHF.
Get free Addex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 121,089 CHF
- Operating income
- -27,010,414 CHF
- Net income
- -26,611,480 CHF
- Operating cash flow
- -29,452,938 CHF